By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Asterias Biotherapeutics 

230 Constitution Drive

Menlo Park  California  94025  U.S.A.
Phone: 650-433-2992 Fax: n/a



Company News
Asterias Biotherapeutics Announces Oral Presentation At ASGCT 19th Annual Meeting 5/2/2016 7:49:49 AM
Howard I. Scher M.D., Leading Clinical Oncology Expert, Joins The Board Of Directors Of Asterias Biotherapeutics 4/28/2016 6:19:47 AM
Asterias Biotherapeutics To Present At Stem Cell Summit 2016 4/26/2016 8:58:32 AM
Asterias Biotherapeutics Announces Record Date For Distribution Of Warrants To Holders Of Asterias Series A Common Stock 4/1/2016 7:01:25 AM
Asterias Biotherapeutics Reports Fourth Quarter And Full Year 2015 Financial Results And Reviews The Company's Three Clinical-Stage Cell Therapy Programs 3/30/2016 6:37:08 AM
Asterias Biotherapeutics To Report Fourth Quarter And Full Year 2015 Results On March 29, 2016 3/23/2016 7:29:49 AM
Asterias Biotherapeutics Names New CEO 2/29/2016 6:48:17 AM
BioTime (BTX) Subsidiary Asterias Biotherapeutics Reports The Successful End-Of-Phase II FDA Meeting For Immunotherapy In Acute Myeloid Leukemia 2/24/2016 11:28:10 AM
Asterias Biotherapeutics Announces Successful End-Of-Phase 2 Meeting With FDA For AST-VAC1 2/24/2016 6:44:10 AM
BioTime (BTX) And Asterias Biotherapeutics Sign Share Transfer Agreement And Cross-License Agreement For Pluripotent Stem Cell Related Patents 2/17/2016 11:32:41 AM